Related Experiment Video
Updated: Sep 17, 2025

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
[Expression and Clinical Significance of CaMKIIγ in Patients with Acute Myeloid Leukemia]
Ming-Kai Liu1, Xu Dai1, Xiao-Ying Zhao1
1Department of Laboratory Medicine, The First Affiliated Hospital of Shihezi University, Shihezi 832008, Xinjiang Uygur Autonomous Region, China.
Objective:
To investigate the expression and potential mechanism of calcium/calmodulin-dependent protein kinase II gamma (CaMKIIγ) in patients with acute myeloid leukemia (AML).
Methods:
Peripheral blood samples were collected from 90 AML patients, and mononuclear cells were isolated. The expression of CaMKIIγ was measured using real-time quantitative PCR and Western blot. The diagnostic value of CaMKIIγ for AML was assessed, and its correlation with clinical characteristics was analyzed using the clinical data of patients. Additionally, the molecular mechanisms of CaMKIIγ were preliminarily explored.
Results:
Compared with the control group, the expression of CaMKIIγ was significantly upregulated in AML patients. Receiver operating characteristic (ROC) curve analysis showed that CaMKIIγ could serve as a promising biomarker for distinguishing AML patients from healthy individuals. Furthermore, CaMKIIγ was significantly correlated with white blood cell (WBC) count and FLT3-ITD mutation. CaMKIIγ was highly expressed in both newly diagnosed and relapsed AML patients, while decreased during remission. In AML cell lines, the expression levels of CaMKIIγ were all elevated. Inhibition of phosphorylated CaMKIIγ by berbamine led to a decrease in pAKT and pSTAT5 expression.
Conclusion:
CaMKIIγ is significantly upregulated in AML patients, and is associated with poor clinicopathological features and unfavorable prognosis. It may serve as a prognostic marker and potential therapeutic target in AML. Its expression may be related to the activation of pAKT and pSTAT5, suggesting that CaMKIIγ may contribute to the development and progression of AML through the activation of the AKT/STAT5 signaling pathway.
Insights
Calcium/calmodulin-dependent protein kinase II gamma (CaMKIIγ) is upregulated in acute myeloid leukemia (AML) patients, acting as a potential biomarker and therapeutic target. Its elevated expression correlates with poor prognosis and may involve the AKT/STAT5 pathway.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Context:
- Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy with complex molecular underpinnings.
- Understanding novel molecular markers and pathways is crucial for improving AML diagnosis and treatment.
- Calcium/calmodulin-dependent protein kinase II gamma (CaMKIIγ) role in AML pathogenesis is not well-defined.
Purpose:
- To investigate the expression levels of CaMKIIγ in AML patients.
- To assess the diagnostic and prognostic value of CaMKIIγ in AML.
- To explore the potential molecular mechanisms underlying CaMKIIγ's role in AML, including its association with signaling pathways like AKT/STAT5.
Summary:
- CaMKIIγ expression was significantly upregulated in peripheral blood mononuclear cells of 90 AML patients compared to controls.
- CaMKIIγ demonstrated diagnostic potential as a biomarker for AML and correlated with white blood cell count and FLT3-ITD mutation.
- Inhibition of phosphorylated CaMKIIγ reduced pAKT and pSTAT5 expression, suggesting its involvement in the AKT/STAT5 signaling pathway crucial for AML progression.
Impact:
- CaMKIIγ serves as a potential prognostic marker and therapeutic target in AML.
- The findings suggest CaMKIIγ contributes to AML development and progression via the AKT/STAT5 pathway.
- This research provides a foundation for developing targeted therapies aimed at CaMKIIγ in AML treatment strategies.
Related Concept Videos
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
cAMP-dependent Protein Kinase Pathways
MAPK Signaling Cascades

